bpc 157 5ht2a 1209_S7_article_22 BPC-157 – Mark Hyman, MD

Molecular mechanisms of lidocaine

Without such trials, it is not possible to definitively establish what dose BPC-157 do in the human body, what an appropriate human research framework would look like, what the human safety profile is, or what conditions if any it might effectively address in clinical practice

As mentioned in the nasal device section, drugs delivered with conventional nasal nebulizer devices deposit in the nasal vestibule and nasal valve regions and do not reach the olfactory region [9,44]

And so thats a really small number of people

Furthermore, for oral use, the form of BPC-157 matters immensely